Paradoxical haemolysis in a patient with cold agglutinin disease

European Journal of Haematology

Volumn 60, Issue 2, 1998, Pages 93-100

  Ulvestad, E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood; Cells; Cold agglutinin disease; Complement; Haemolysis

Indexed keywords

COLD AGGLUTININ; COMPLEMENT; COMPLEMENT COMPONENT C4;

ACUTE PHASE RESPONSE; AGED; ARTICLE; BODY TEMPERATURE; CASE REPORT; COLD EXPOSURE; COMPLEMENT SYSTEM; HEMOLYSIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031918434     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01004.x     Document Type: Article

References (19)

1. NYDEGGER UE, KAZATCHINKE MD, MIESCHER PA. Immunopathological and clinical features of haemolytic anaemia due to cold agglutinin. Semin Hematol 1991: 28: 66-77.
2. BERENTSEN S, BØ K, SHAMMAS FV, MYKING AO, ULVESTAD E. Chronic cold agglutinin disease of the "idiopatic" type is a premalignant or low-grade malignant lymphoproliferative disease. APMIS 1997: 105: 354-362.
3. ROSSE WF, ADAMS J, LOGUE G. Haemolysis by complement and cold-reacting antibodies: time and temperature requirements. Am J Hematol 1977: 2: 259-270.
4. ATKINSON JP, FRANK MM. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest 1974: 54: 339-348.
5. ROLCKE D. Cold agglutination. Transfus Med Rev 1989: 2: 140-166.
6. H4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992: 149: 2337-2344.
7. H4-21, specifically encodes autoanti-red cell antibodies against the I or i antigens. Vox Sang 1995: 68: 231-235.
8. H framework region 1 and complementarity determining region 3. J Mol Biol 1996: 256: 577-589.
9. GARRED P, MOLLNES TE, LEA T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988: 27: 329-335.
10. MOLLNES TE, LEA T, FROLAND SS, HARBOE M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorhent assay base on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985: 22: 197-202.
11. HARBOE M, TORSVIK H. Protein abnormalities in the cold haemagglutinin syndrome. Scand J Haemat 1969: 6: 416-426.
12. BRUN A, SKADBERG Ø, HERVIG TA, SANDBERG S. Phenotyping autologous red cells within 1 day after allogeneic blood transfusion by using immunomagnetic isolation of reticulocytes. Transfusion 1994: 34: 162-166.
13. PORCEL JM, PEAKMAN M, SENALDI G, VERGANI D. Methods for assessing complement activation in the clinical immunology laboratory. J Immunol Methods 1993: 157: 1-9.
14. VOLANAKIS JE. Transcriptional regulation of complement genes. Annu Rev Immunol 1995: 13: 277-305.
15. FEIZI T, WERNET P, KUNKEL HG, DOUGLAS SD. Lymphocytes forming red cell rosettes in the cold in patients with chronic cold agglutinin disease. Blood 1973: 42: 753-762.
16. UMLAS J, KAUFMAN M, MACQUESTON C, SORBA S, DAINIAK N. A cryoglobulin with cold agglutinin and erythroid stem cell suppressant properties. Transfusion 1991: 31: 361-364.
17. ZAGO-NOVARETTI M, KHURI F, MILLER KB, BERKMAN EM. Waldenstrom's macroglobulinemia with an IgM paraprotein that is both a cold agglutinin and a cryoglobulin and has a suppressive effect on progenitor cell growth. Transfusion 1994: 34: 910-914.
18. TAFT EG, PROPP RP, SULLIVAN SA. Plasma exchange for cold agglutinin haemolytic anaemia. Transfusion 1977: 17: 173-176.
19. Hillestad LK. The peripheral circulation during exposure to cold in normals and in patients with the syndrome of high-titre cold haemagglutination. Acta Med Scand 1959: 164: 211-218.